These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

803 related items for PubMed ID: 11177538

  • 1. Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications.
    Paquin A, Jaalouk DE, Galipeau J.
    Hum Gene Ther; 2001 Jan 01; 12(1):13-23. PubMed ID: 11177538
    [Abstract] [Full Text] [Related]

  • 2. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
    Galipeau J, Li H, Paquin A, Sicilia F, Karpati G, Nalbantoglu J.
    Cancer Res; 1999 May 15; 59(10):2384-94. PubMed ID: 10344748
    [Abstract] [Full Text] [Related]

  • 3. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD, Boenicke L, Schniewind B, Henne-Bruns D, Kalthoff H.
    Cancer Gene Ther; 2000 Jun 15; 7(6):927-38. PubMed ID: 10880025
    [Abstract] [Full Text] [Related]

  • 4. Herpes simplex virus thymidine kinase-green fluorescent protein fusion gene: new tool for gene transfer studies and gene therapy.
    Loimas S, Wahlfors J, Jänne J.
    Biotechniques; 1998 Apr 15; 24(4):614-8. PubMed ID: 9564534
    [Abstract] [Full Text] [Related]

  • 5. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer.
    Rancourt C, Bergeron C, Lane D, Garon G, Piché A.
    Cytotherapy; 2003 Apr 15; 5(6):509-22. PubMed ID: 14660047
    [Abstract] [Full Text] [Related]

  • 6. TK-GFP fusion gene virus vectors as tools for studying the features of HSV-TK/ganciclovir cancer gene therapy in vivo.
    Pasanen T, Hakkarainen T, Timonen P, Parkkinen J, Tenhunen A, Loimas S, Wahlfors J.
    Int J Mol Med; 2003 Oct 15; 12(4):525-31. PubMed ID: 12964030
    [Abstract] [Full Text] [Related]

  • 7. Bystander-mediated regression of osteosarcoma via retroviral transfer of the herpes simplex virus thymidine kinase and human interleukin-2 genes.
    Walling HW, Swarthout JT, Culver KW.
    Cancer Gene Ther; 2000 Feb 15; 7(2):187-96. PubMed ID: 10770626
    [Abstract] [Full Text] [Related]

  • 8. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
    Qiao J, Moreno J, Sanchez-Perez L, Kottke T, Thompson J, Caruso M, Diaz RM, Vile R.
    Gene Ther; 2006 Oct 15; 13(20):1457-70. PubMed ID: 16724095
    [Abstract] [Full Text] [Related]

  • 9. Abnormal expression of only the CD34 part of a transgenic CD34/herpes simplex virus-thymidine kinase fusion protein is associated with ganciclovir resistance.
    Bennour E, Ferrand C, Rémy-Martin JP, Certoux JM, Gorke S, Qasim W, Gaspar HB, Baumert T, Duperrier A, Deschamps M, Fehse B, Tiberghien P, Robinet E.
    Hum Gene Ther; 2008 Jul 15; 19(7):699-709. PubMed ID: 18557699
    [Abstract] [Full Text] [Related]

  • 10. [Vesicular stomatitis virus G-protein retrovector mediated a herpes simplex virus thymidine kinase gene transduction and expression in the human retinal pigment epithelial cells].
    Wang F, Wang HW, Lu DR, Xue JL, Zhang X.
    Zhonghua Yan Ke Za Zhi; 2003 Apr 15; 39(4):201-5. PubMed ID: 12882696
    [Abstract] [Full Text] [Related]

  • 11. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.
    J Gene Med; 2004 Mar 15; 6(3):288-99. PubMed ID: 15026990
    [Abstract] [Full Text] [Related]

  • 12. Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression.
    Jacobs A, Dubrovin M, Hewett J, Sena-Esteves M, Tan CW, Slack M, Sadelain M, Breakefield XO, Tjuvajev JG.
    Neoplasia; 1999 Jun 15; 1(2):154-61. PubMed ID: 10933050
    [Abstract] [Full Text] [Related]

  • 13. Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation.
    Shibata MA, Morimoto J, Otsuki Y.
    Cancer Gene Ther; 2002 Jan 15; 9(1):16-27. PubMed ID: 11916241
    [Abstract] [Full Text] [Related]

  • 14. Hepatoma cell-specific ganciclovir-mediated toxicity of a lentivirally transduced HSV-TkEGFP fusion protein gene placed under the control of rat alpha-fetoprotein gene regulatory sequences.
    Uch R, Gérolami R, Faivre J, Hardwigsen J, Mathieu S, Mannoni P, Bagnis C.
    Cancer Gene Ther; 2003 Sep 15; 10(9):689-95. PubMed ID: 12944988
    [Abstract] [Full Text] [Related]

  • 15. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors.
    Ram Z, Culver KW, Walbridge S, Frank JA, Blaese RM, Oldfield EH.
    J Neurosurg; 1993 Sep 15; 79(3):400-7. PubMed ID: 8395592
    [Abstract] [Full Text] [Related]

  • 16. Use of a herpes thymidine kinase/neomycin phosphotransferase chimeric gene for metabolic suicide gene transfer.
    Candotti F, Agbaria R, Mullen CA, Touraine R, Balzarini J, Johns DG, Blaese RM.
    Cancer Gene Ther; 2000 Apr 15; 7(4):574-80. PubMed ID: 10811475
    [Abstract] [Full Text] [Related]

  • 17. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Ram Z, Culver KW, Walbridge S, Blaese RM, Oldfield EH.
    Cancer Res; 1993 Jan 01; 53(1):83-8. PubMed ID: 8380127
    [Abstract] [Full Text] [Related]

  • 18. VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct.
    Hakkarainen T, Wahlfors T, Meriläinen O, Loimas S, Hemminki A, Wahlfors J.
    J Gene Med; 2005 Jul 01; 7(7):898-907. PubMed ID: 15759279
    [Abstract] [Full Text] [Related]

  • 19. Green fluorescent protein retroviral vectors: low titer and high recombination frequency suggest a selective disadvantage.
    Hanazono Y, Yu JM, Dunbar CE, Emmons RV.
    Hum Gene Ther; 1997 Jul 20; 8(11):1313-9. PubMed ID: 9295126
    [Abstract] [Full Text] [Related]

  • 20. Generation of fusion genes carrying drug resistance, green fluorescent protein, and herpes simplex virus thymidine kinase genes in a single cistron.
    Oh SC, Nam SY, Kwon HC, Kim CM, Seo JS, Seong RH, Jang YJ, Chung YH, Chung HY.
    Mol Cells; 2001 Apr 30; 11(2):192-7. PubMed ID: 11355700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.